Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


University of Genoa

Latest From University of Genoa

Breast Cancer Detection: New Technologies Push the Envelope

Technologies for breast cancer detection are evolving rapidly as manufacturers work to push the diagnostic envelope beyond standard screening mammography, ultrasound technology, and magnetic resonance imaging. At two recent meetings, the November 2010 meeting of the Radiology Society of North America and the March 2011 meeting of the European Congress of Radiology, several presentations focused on the latest research and technology developments in breast cancer detection.

Medical Device

New Developments in Obesity Intervention

With soaring medical costs weighing heavily on the US economy, it's not surprising that obesity has become a target in the health care reform debate. Obesity is costly because it significantly increases the risk of many chronic diseases. Exercise, dieting and prescription drugs have had a limited effect in stemming the tide of obesity, leaving bariatric surgery and other interventional techniques as the primary treatment options for this potentially multi-billion dollar market. But device manufacturers have a challenge ahead of them--to develop more effective, safer, and less invasive obesity therapies that will not only result in long-term weight loss, but will also cut treatment costs and better manage comorbidities.

Medical Device
See All

Company Information

  • Industry
  • Academic and Research Institutions